XTL BIOPHARMACEUTICALS-ADR (XTLB)

US98386D3070 - ADR

2.6  -0.08 (-2.99%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2019-6-30)
2018
(2018-12-31)
2017
(2017-12-31)
2016
(2016-12-31)
2015
(2015-12-31)
Revenue
0.000.000.000.000.00
Minority Interest Expense
N/AN/AN/AN/A0.00
Operating Expenses
810.00K790.00K1.25M1.71M2.01M
Research and Development
40.00K40.00K40.00K440.00K580.00K
Selling, General, and Administrative Expenses
770.00K760.00K1.20M1.27M1.42M
Operating Income
-810.00K-790.00K-1.25M-1.71M-2.01M
Interest Income/Expense
2.53M60.00K40.00K20.00K-10.00K
Other Income/Expense
N/A3.72M430.00K0.0010.00K
Non Recurring Items
N/A0.000.00-850.00K-1.60M
Income Before Taxes
3.10M2.99M-780.00K-2.55M-3.62M
Net Income
3.10M2.99M-780.00K-2.55M-4.31M
EBITDA
N/AN/AN/AN/A-2.00M
 
Per Share Data
EPS Diluted Total Ops
0.600.58-0.17-0.93-8.17
 
Statistics

All data in USD

Charts